Reports

Industry Research Reports

Home > Reports > Service & Software > Global Artificial Intelligence in Biomedical Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032

Global Artificial Intelligence in Biomedical Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032

Global Artificial Intelligence in Biomedical Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032

Industry: Service & Software

Published Date: 2026-03-24

Pages: 118 Pages

Report ld: 6270093

application for samples

Request Sample

Custom reports

Customized Report

  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected
  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected

Artificial Intelligence in Biomedical Market Size(US$)

den_QYR1
cagr

CAGR 2026-2032

30.1%

marketSize

Market Size,2032

USD 1,545

Million

Market Snapshot

Market Size in 2026 (Value)
US$ 318 million
Market Forecast in 2032(Value)
US$ 1,545 million
CAGR
30.1%
Years Considered
2021-2032
Base Year
2026
Forecast Period
2026-2032

Source: Secondary research, interviews with experts, and QYResearch analysis

The global Artificial Intelligence in Biomedical market size was US$ 250 million in 2025 and is forecast to reach a readjusted size of US$ 1545 million by 2032 with a CAGR of 30.1% during the forecast period 2026-2032.

Artificial Intelligence (AI) in biomedical refers to the application of AI technologies, such as machine learning, natural language processing, and computer vision, in the fields of medicine and biology. It is used to analyze complex biomedical data, assist in diagnostics, develop personalized treatment plans, discover new drugs, and improve healthcare outcomes. AI enhances the accuracy, speed, and efficiency of medical and biological research and clinical practices.

In 2025, the North America Artificial Intelligence in Biomedical market was US$ million, while the Europe market stood at US$ million. North America accounted for % of the global market in 2025 and Europe for %. Europe’s share is expected to reach % by 2032, corresponding to a CAGR of % over the analysis period.

The global key players of Artificial Intelligence in Biomedical include AstraZeneca, Thales Group, IBM Corp., ForeSee Medical, Atomwise, Cloud Pharmaceuticals, GNS Healthcare, Microsoft Corporation, Novartis AG, NVIDIA Corporation, among others. In 2025, the top five players accounted for approximately % of global market revenue.

In terms of revenue, the top three players in North America accounted for about % of the market in 2025, while the top three in Europe held nearly %.

The global Artificial Intelligence in Biomedical market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2021-2032.

MARKET SEGMENTATION

By Company

  • AstraZeneca
  • Thales Group
  • IBM Corp.
  • ForeSee Medical
  • Atomwise
  • Cloud Pharmaceuticals
  • GNS Healthcare
  • Microsoft Corporation
  • Novartis AG
  • NVIDIA Corporation
  • Pfizer
  • Recursion Pharmaceuticals
  • XtalPi Inc
  • Aidoc
  • AliveCor
  • GE Healthcare
  • Imagen Technologies
  • Vuno Inc.
  • IDx Technologies Inc.
  • Siemens Healthcare GmbH
  • Neural Analytics

Consumption by Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Segment by Type

  • Hardware
  • Software

Segment by Application

  • Diagnosing Diseases
  • Developing Drugs
  • Personalized Treatment
  • Other

WHY THIS REPORT

Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Artificial Intelligence in Biomedical value chain, addressing:

- Market entry risks/opportunities by region

- Product mix optimization based on local practices

- Competitor tactics in fragmented vs. consolidated markets

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region
Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

den_ic6
Product mix optimization based on local practices
Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

den_ic6
Competitor tactics in fragmented vs. consolidated markets
Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

den_ic6
Full Research Coverage
Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

den_ic6
19 Years Industry Expertise
19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

den_ic6
24/7 Fast Report Delivery
24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

den_ic6
Localized Strategic Analysis
Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

den_ic6
Market entry risks/opportunities by region
Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

den_ic6
Market entry risks/opportunities by region
Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

den_ic6
den_biaoTiZhungShi

TABLE OF CONTENTS

muLu

1 Report Overview

1.1 Study Scope

1.2 Market by Type

1.2.1 Global Market Size and Growth by Type: 2021 vs 2025 vs 2032

1.2.2 Hardware

1.2.3 Software

1.3 Market by Application

1.3.1 Global Market Share by Application: 2021 vs 2025 vs 2032

1.3.2 Diagnosing Diseases

1.3.3 Developing Drugs

1.3.4 Personalized Treatment

1.3.5 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

muLu

2 Global Growth Trends

2.1 Global Artificial Intelligence in Biomedical Market Perspective (2021-2032)

2.2 Global Market Size by Region: 2021 vs 2025 vs 2032

2.3 Global Artificial Intelligence in Biomedical Market Share by Revenue, by Region (2021-2026)

2.4 Global Artificial Intelligence in Biomedical Revenue Forecast by Region (2027-2032)

2.5 Major Regions and Emerging Markets Analysis

2.5.1 North America Artificial Intelligence in Biomedical Market Size and Prospective (2021-2032)

2.5.2 Europe Artificial Intelligence in Biomedical Market Size and Prospective (2021-2032)

2.5.3 Asia-Pacific Artificial Intelligence in Biomedical Market Size and Prospective (2021-2032)

2.5.4 Latin America Artificial Intelligence in Biomedical Market Size and Prospective (2021-2032)

2.5.5 Middle East & Africa Artificial Intelligence in Biomedical Market Size and Prospective (2021-2032)

muLu

3 Breakdown Data by Type

3.1 Global Artificial Intelligence in Biomedical Historical Market Size by Type (2021-2026)

3.2 Global Artificial Intelligence in Biomedical Forecasted Market Size by Type (2027-2032)

3.3 Representative Players for Different Types of Artificial Intelligence in Biomedical

muLu

4 Breakdown Data by Application

4.1 Global Artificial Intelligence in Biomedical Historical Market Size by Application (2021-2026)

4.2 Global Artificial Intelligence in Biomedical Forecasted Market Size by Application (2027-2032)

4.3 New Sources of Growth in Artificial Intelligence in Biomedical Applications

muLu

5 Competitive Landscape by Players

5.1 Global Top Players by Revenue

5.1.1 Global Top Artificial Intelligence in Biomedical Players by Revenue (2021-2026)

5.1.2 Global Artificial Intelligence in Biomedical Market Share by Revenue, by Players (2021-2026)

5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

5.3 Players Covered: Ranking by Artificial Intelligence in Biomedical Revenue

5.4 Global Artificial Intelligence in Biomedical Market Concentration Analysis

5.4.1 Global Artificial Intelligence in Biomedical Market Concentration Ratio (CR5 and HHI)

5.4.2 Global Top 10 and Top 5 Companies by Artificial Intelligence in Biomedical Revenue in 2025

5.5 Global Key Players of Artificial Intelligence in Biomedical Head Offices and Areas Served

5.6 Global Key Players of Artificial Intelligence in Biomedical, Product and Application

5.7 Global Key Players of Artificial Intelligence in Biomedical, Date of Entry into This Industry

5.8 Mergers & Acquisitions, Expansion Plans

muLu

6 Region Analysis

6.1 North America Market: Players, Segments, Downstream and Major Customers

6.1.1 North America Artificial Intelligence in Biomedical Revenue by Company (2021-2026)

6.1.2 North America Market Size by Type

6.1.2.1 North America Artificial Intelligence in Biomedical Market Size by Type (2021-2026)

6.1.2.2 North America Artificial Intelligence in Biomedical Market Share by Type (2021-2026)

6.1.3 North America Market Size by Application

6.1.3.1 North America Artificial Intelligence in Biomedical Market Size by Application (2021-2026)

6.1.3.2 North America Artificial Intelligence in Biomedical Market Share by Application (2021-2026)

6.1.4 North America Artificial Intelligence in Biomedical Major Customers

6.1.5 North America Market Trends and Opportunities

6.2 Europe Market: Players, Segments, Downstream and Major Customers

6.2.1 Europe Artificial Intelligence in Biomedical Revenue by Company (2021-2026)

6.2.2 Europe Market Size by Type

6.2.2.1 Europe Artificial Intelligence in Biomedical Market Size by Type (2021-2026)

6.2.2.2 Europe Artificial Intelligence in Biomedical Market Share by Type (2021-2026)

6.2.3 Europe Market Size by Application

6.2.3.1 Europe Artificial Intelligence in Biomedical Market Size by Application (2021-2026)

6.2.3.2 Europe Artificial Intelligence in Biomedical Market Share by Application (2021-2026)

6.2.4 Europe Artificial Intelligence in Biomedical Major Customers

6.2.5 Europe Market Trends and Opportunities

6.3 Asia-Pacific Market: Players, Segments, Downstream and Major Customers

6.3.1 Asia-Pacific Artificial Intelligence in Biomedical Revenue by Company (2021-2026)

6.3.2 Asia-Pacific Market Size by Type

6.3.2.1 Asia-Pacific Artificial Intelligence in Biomedical Market Size by Type (2021-2026)

6.3.2.2 Asia-Pacific Artificial Intelligence in Biomedical Market Share by Type (2021-2026)

6.3.3 Asia-Pacific Market Size by Application

6.3.3.1 Asia-Pacific Artificial Intelligence in Biomedical Market Size by Application (2021-2026)

6.3.3.2 Asia-Pacific Artificial Intelligence in Biomedical Market Share by Application (2021-2026)

6.3.4 Asia-Pacific Artificial Intelligence in Biomedical Major Customers

6.3.5 Asia-Pacific Market Trends and Opportunities

6.4 Latin America Market: Players, Segments, Downstream and Major Customers

6.4.1 Latin America Artificial Intelligence in Biomedical Revenue by Company (2021-2026)

6.4.2 Latin America Market Size by Type

6.4.2.1 Latin America Artificial Intelligence in Biomedical Market Size by Type (2021-2026)

6.4.2.2 Latin America Artificial Intelligence in Biomedical Market Share by Type (2021-2026)

6.4.3 Latin America Market Size by Application

6.4.3.1 Latin America Artificial Intelligence in Biomedical Market Size by Application (2021-2026)

6.4.3.2 Latin America Artificial Intelligence in Biomedical Market Share by Application (2021-2026)

6.4.4 Latin America Artificial Intelligence in Biomedical Major Customers

6.4.5 Latin America Market Trends and Opportunities

6.5 Middle East & Africa Market: Players, Segments, Downstream and Major Customers

6.5.1 Middle East & Africa Artificial Intelligence in Biomedical Revenue by Company (2021-2026)

6.5.2 Middle East & Africa Market Size by Type

6.5.2.1 Middle East & Africa Artificial Intelligence in Biomedical Market Size by Type (2021-2026)

6.5.2.2 Middle East & Africa Artificial Intelligence in Biomedical Market Share by Type (2021-2026)

6.5.3 Middle East & Africa Market Size by Application

6.5.3.1 Middle East & Africa Artificial Intelligence in Biomedical Market Size by Application (2021-2026)

6.5.3.2 Middle East & Africa Artificial Intelligence in Biomedical Market Share by Application (2021-2026)

6.5.4 Middle East & Africa Artificial Intelligence in Biomedical Major Customers

6.5.5 Middle East & Africa Market Trends and Opportunities

muLu

7 Key Player Profiles

7.1 AstraZeneca

7.1.1 AstraZeneca Company Details

7.1.2 AstraZeneca Business Overview

7.1.3 AstraZeneca Artificial Intelligence in Biomedical Introduction

7.1.4 AstraZeneca Revenue in Artificial Intelligence in Biomedical Business (2021-2026)

7.1.5 AstraZeneca Recent Development

7.2 Thales Group

7.2.1 Thales Group Company Details

7.2.2 Thales Group Business Overview

7.2.3 Thales Group Artificial Intelligence in Biomedical Introduction

7.2.4 Thales Group Revenue in Artificial Intelligence in Biomedical Business (2021-2026)

7.2.5 Thales Group Recent Development

7.3 IBM Corp.

7.3.1 IBM Corp. Company Details

7.3.2 IBM Corp. Business Overview

7.3.3 IBM Corp. Artificial Intelligence in Biomedical Introduction

7.3.4 IBM Corp. Revenue in Artificial Intelligence in Biomedical Business (2021-2026)

7.3.5 IBM Corp. Recent Development

7.4 ForeSee Medical

7.4.1 ForeSee Medical Company Details

7.4.2 ForeSee Medical Business Overview

7.4.3 ForeSee Medical Artificial Intelligence in Biomedical Introduction

7.4.4 ForeSee Medical Revenue in Artificial Intelligence in Biomedical Business (2021-2026)

7.4.5 ForeSee Medical Recent Development

7.5 Atomwise

7.5.1 Atomwise Company Details

7.5.2 Atomwise Business Overview

7.5.3 Atomwise Artificial Intelligence in Biomedical Introduction

7.5.4 Atomwise Revenue in Artificial Intelligence in Biomedical Business (2021-2026)

7.5.5 Atomwise Recent Development

7.6 Cloud Pharmaceuticals

7.6.1 Cloud Pharmaceuticals Company Details

7.6.2 Cloud Pharmaceuticals Business Overview

7.6.3 Cloud Pharmaceuticals Artificial Intelligence in Biomedical Introduction

7.6.4 Cloud Pharmaceuticals Revenue in Artificial Intelligence in Biomedical Business (2021-2026)

7.6.5 Cloud Pharmaceuticals Recent Development

7.7 GNS Healthcare

7.7.1 GNS Healthcare Company Details

7.7.2 GNS Healthcare Business Overview

7.7.3 GNS Healthcare Artificial Intelligence in Biomedical Introduction

7.7.4 GNS Healthcare Revenue in Artificial Intelligence in Biomedical Business (2021-2026)

7.7.5 GNS Healthcare Recent Development

7.8 Microsoft Corporation

7.8.1 Microsoft Corporation Company Details

7.8.2 Microsoft Corporation Business Overview

7.8.3 Microsoft Corporation Artificial Intelligence in Biomedical Introduction

7.8.4 Microsoft Corporation Revenue in Artificial Intelligence in Biomedical Business (2021-2026)

7.8.5 Microsoft Corporation Recent Development

7.9 Novartis AG

7.9.1 Novartis AG Company Details

7.9.2 Novartis AG Business Overview

7.9.3 Novartis AG Artificial Intelligence in Biomedical Introduction

7.9.4 Novartis AG Revenue in Artificial Intelligence in Biomedical Business (2021-2026)

7.9.5 Novartis AG Recent Development

7.10 NVIDIA Corporation

7.10.1 NVIDIA Corporation Company Details

7.10.2 NVIDIA Corporation Business Overview

7.10.3 NVIDIA Corporation Artificial Intelligence in Biomedical Introduction

7.10.4 NVIDIA Corporation Revenue in Artificial Intelligence in Biomedical Business (2021-2026)

7.10.5 NVIDIA Corporation Recent Development

7.11 Pfizer

7.11.1 Pfizer Company Details

7.11.2 Pfizer Business Overview

7.11.3 Pfizer Artificial Intelligence in Biomedical Introduction

7.11.4 Pfizer Revenue in Artificial Intelligence in Biomedical Business (2021-2026)

7.11.5 Pfizer Recent Development

7.12 Recursion Pharmaceuticals

7.12.1 Recursion Pharmaceuticals Company Details

7.12.2 Recursion Pharmaceuticals Business Overview

7.12.3 Recursion Pharmaceuticals Artificial Intelligence in Biomedical Introduction

7.12.4 Recursion Pharmaceuticals Revenue in Artificial Intelligence in Biomedical Business (2021-2026)

7.12.5 Recursion Pharmaceuticals Recent Development

7.13 XtalPi Inc

7.13.1 XtalPi Inc Company Details

7.13.2 XtalPi Inc Business Overview

7.13.3 XtalPi Inc Artificial Intelligence in Biomedical Introduction

7.13.4 XtalPi Inc Revenue in Artificial Intelligence in Biomedical Business (2021-2026)

7.13.5 XtalPi Inc Recent Development

7.14 Aidoc

7.14.1 Aidoc Company Details

7.14.2 Aidoc Business Overview

7.14.3 Aidoc Artificial Intelligence in Biomedical Introduction

7.14.4 Aidoc Revenue in Artificial Intelligence in Biomedical Business (2021-2026)

7.14.5 Aidoc Recent Development

7.15 AliveCor

7.15.1 AliveCor Company Details

7.15.2 AliveCor Business Overview

7.15.3 AliveCor Artificial Intelligence in Biomedical Introduction

7.15.4 AliveCor Revenue in Artificial Intelligence in Biomedical Business (2021-2026)

7.15.5 AliveCor Recent Development

7.16 GE Healthcare

7.16.1 GE Healthcare Company Details

7.16.2 GE Healthcare Business Overview

7.16.3 GE Healthcare Artificial Intelligence in Biomedical Introduction

7.16.4 GE Healthcare Revenue in Artificial Intelligence in Biomedical Business (2021-2026)

7.16.5 GE Healthcare Recent Development

7.17 Imagen Technologies

7.17.1 Imagen Technologies Company Details

7.17.2 Imagen Technologies Business Overview

7.17.3 Imagen Technologies Artificial Intelligence in Biomedical Introduction

7.17.4 Imagen Technologies Revenue in Artificial Intelligence in Biomedical Business (2021-2026)

7.17.5 Imagen Technologies Recent Development

7.18 Vuno Inc.

7.18.1 Vuno Inc. Company Details

7.18.2 Vuno Inc. Business Overview

7.18.3 Vuno Inc. Artificial Intelligence in Biomedical Introduction

7.18.4 Vuno Inc. Revenue in Artificial Intelligence in Biomedical Business (2021-2026)

7.18.5 Vuno Inc. Recent Development

7.19 IDx Technologies Inc.

7.19.1 IDx Technologies Inc. Company Details

7.19.2 IDx Technologies Inc. Business Overview

7.19.3 IDx Technologies Inc. Artificial Intelligence in Biomedical Introduction

7.19.4 IDx Technologies Inc. Revenue in Artificial Intelligence in Biomedical Business (2021-2026)

7.19.5 IDx Technologies Inc. Recent Development

7.20 Siemens Healthcare GmbH

7.20.1 Siemens Healthcare GmbH Company Details

7.20.2 Siemens Healthcare GmbH Business Overview

7.20.3 Siemens Healthcare GmbH Artificial Intelligence in Biomedical Introduction

7.20.4 Siemens Healthcare GmbH Revenue in Artificial Intelligence in Biomedical Business (2021-2026)

7.20.5 Siemens Healthcare GmbH Recent Development

7.21 Neural Analytics

7.21.1 Neural Analytics Company Details

7.21.2 Neural Analytics Business Overview

7.21.3 Neural Analytics Artificial Intelligence in Biomedical Introduction

7.21.4 Neural Analytics Revenue in Artificial Intelligence in Biomedical Business (2021-2026)

7.21.5 Neural Analytics Recent Development

muLu

8 Artificial Intelligence in Biomedical Market Dynamics

8.1 Artificial Intelligence in Biomedical Industry Trends

8.2 Artificial Intelligence in Biomedical Market Drivers

8.3 Artificial Intelligence in Biomedical Market Challenges

8.4 Artificial Intelligence in Biomedical Market Restraints

muLu

9 Research Findings and Conclusion

muLu

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

den_biaoTiZhungShi

TABLE OF FIGURES

muLu

List of Tables

Table 1. Global Artificial Intelligence in Biomedical Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Global Artificial Intelligence in Biomedical Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 3. Global Market Artificial Intelligence in Biomedical Market Size (US$ Million) by Region:2021 vs 2025 vs 2032
Table 4. Global Artificial Intelligence in Biomedical Revenue (US$ Million) Market Share by Region (2021-2026)
Table 5. Global Artificial Intelligence in Biomedical Revenue Share by Region (2021-2026)
Table 6. Global Artificial Intelligence in Biomedical Revenue (US$ Million) Forecast by Region (2027-2032)
Table 7. Global Artificial Intelligence in Biomedical Revenue Share Forecast by Region (2027-2032)
Table 8. Global Artificial Intelligence in Biomedical Market Size by Type (2021-2026) & (US$ Million)
Table 9. Global Artificial Intelligence in Biomedical Market Share by Revenue, by Type (2021-2026)
Table 10. Global Artificial Intelligence in Biomedical Forecasted Market Size by Type (2027-2032) & (US$ Million)
Table 11. Global Artificial Intelligence in Biomedical Market Share by Revenue, by Type (2027-2032)
Table 12. Representative Players of Each Type
Table 13. Global Artificial Intelligence in Biomedical Market Size by Application (2021-2026) & (US$ Million)
Table 14. Global Artificial Intelligence in Biomedical Market Share by Revenue, by Application (2021-2026)
Table 15. Global Artificial Intelligence in Biomedical Forecasted Market Size by Application (2027-2032) & (US$ Million)
Table 16. Global Artificial Intelligence in Biomedical Market Share by Revenue, by Application (2027-2032)
Table 17. New Sources of Growth in Artificial Intelligence in Biomedical Applications
Table 18. Global Artificial Intelligence in Biomedical Revenue by Players (2021-2026) & (US$ Million)
Table 19. Global Artificial Intelligence in Biomedical Market Share by Players (2021-2026)
Table 20. Global Top Artificial Intelligence in Biomedical Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Artificial Intelligence in Biomedical as of 2025)
Table 21. Ranking of Global Top Artificial Intelligence in Biomedical Companies by Revenue (US$ Million) in 2025
Table 22. Global 5 Largest Players Market Share by Artificial Intelligence in Biomedical Revenue (CR5 and HHI) & (2021-2026)
Table 23. Global Key Players of Artificial Intelligence in Biomedical, Headquarters and Area Served
Table 24. Global Key Players of Artificial Intelligence in Biomedical, Product and Application
Table 25. Global Key Players of Artificial Intelligence in Biomedical, Date of Entry into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. North America Artificial Intelligence in Biomedical Revenue by Company (2021-2026) & (US$ Million)
Table 28. North America Artificial Intelligence in Biomedical Market Share by Revenue, by Company (2021-2026)
Table 29. North America Artificial Intelligence in Biomedical Market Size by Type (2021-2026) & (US$ Million)
Table 30. North America Artificial Intelligence in Biomedical Market Size by Application (2021-2026) & (US$ Million)
Table 31. Europe Artificial Intelligence in Biomedical Revenue by Company (2021-2026) & (US$ Million)
Table 32. Europe Artificial Intelligence in Biomedical Market Share by Revenue, by Company (2021-2026)
Table 33. Europe Artificial Intelligence in Biomedical Market Size by Type (2021-2026) & (US$ Million)
Table 34. Europe Artificial Intelligence in Biomedical Market Size by Application (2021-2026) & (US$ Million)
Table 35. Asia-Pacific Artificial Intelligence in Biomedical Revenue by Company (2021-2026) & (US$ Million)
Table 36. Asia-Pacific Artificial Intelligence in Biomedical Market Share by Revenue, by Company (2021-2026)
Table 37. Asia-Pacific Artificial Intelligence in Biomedical Market Size by Type (2021-2026) & (US$ Million)
Table 38. Asia-Pacific Artificial Intelligence in Biomedical Market Size by Application (2021-2026) & (US$ Million)
Table 39. Latin America Artificial Intelligence in Biomedical Revenue by Company (2021-2026) & (US$ Million)
Table 40. Latin America Artificial Intelligence in Biomedical Market Share by Revenue, by Company (2021-2026)
Table 41. Latin America Artificial Intelligence in Biomedical Market Size by Type (2021-2026) & (US$ Million)
Table 42. Latin America Artificial Intelligence in Biomedical Market Size by Application (2021-2026) & (US$ Million)
Table 43. Middle East & Africa Artificial Intelligence in Biomedical Revenue by Company (2021-2026) & (US$ Million)
Table 44. Middle East & Africa Artificial Intelligence in Biomedical Market Share by Revenue, by Company (2021-2026)
Table 45. Middle East & Africa Artificial Intelligence in Biomedical Market Size by Type (2021-2026) & (US$ Million)
Table 46. Middle East & Africa Artificial Intelligence in Biomedical Market Size by Application (2021-2026) & (US$ Million)
Table 47. AstraZeneca Company Details
Table 48. AstraZeneca Business Overview
Table 49. AstraZeneca Artificial Intelligence in Biomedical Product
Table 50. AstraZeneca Revenue in Artificial Intelligence in Biomedical Business (2021-2026) & (US$ Million)
Table 51. AstraZeneca Recent Development
Table 52. Thales Group Company Details
Table 53. Thales Group Business Overview
Table 54. Thales Group Artificial Intelligence in Biomedical Product
Table 55. Thales Group Revenue in Artificial Intelligence in Biomedical Business (2021-2026) & (US$ Million)
Table 56. Thales Group Recent Development
Table 57. IBM Corp. Company Details
Table 58. IBM Corp. Business Overview
Table 59. IBM Corp. Artificial Intelligence in Biomedical Product
Table 60. IBM Corp. Revenue in Artificial Intelligence in Biomedical Business (2021-2026) & (US$ Million)
Table 61. IBM Corp. Recent Development
Table 62. ForeSee Medical Company Details
Table 63. ForeSee Medical Business Overview
Table 64. ForeSee Medical Artificial Intelligence in Biomedical Product
Table 65. ForeSee Medical Revenue in Artificial Intelligence in Biomedical Business (2021-2026) & (US$ Million)
Table 66. ForeSee Medical Recent Development
Table 67. Atomwise Company Details
Table 68. Atomwise Business Overview
Table 69. Atomwise Artificial Intelligence in Biomedical Product
Table 70. Atomwise Revenue in Artificial Intelligence in Biomedical Business (2021-2026) & (US$ Million)
Table 71. Atomwise Recent Development
Table 72. Cloud Pharmaceuticals Company Details
Table 73. Cloud Pharmaceuticals Business Overview
Table 74. Cloud Pharmaceuticals Artificial Intelligence in Biomedical Product
Table 75. Cloud Pharmaceuticals Revenue in Artificial Intelligence in Biomedical Business (2021-2026) & (US$ Million)
Table 76. Cloud Pharmaceuticals Recent Development
Table 77. GNS Healthcare Company Details
Table 78. GNS Healthcare Business Overview
Table 79. GNS Healthcare Artificial Intelligence in Biomedical Product
Table 80. GNS Healthcare Revenue in Artificial Intelligence in Biomedical Business (2021-2026) & (US$ Million)
Table 81. GNS Healthcare Recent Development
Table 82. Microsoft Corporation Company Details
Table 83. Microsoft Corporation Business Overview
Table 84. Microsoft Corporation Artificial Intelligence in Biomedical Product
Table 85. Microsoft Corporation Revenue in Artificial Intelligence in Biomedical Business (2021-2026) & (US$ Million)
Table 86. Microsoft Corporation Recent Development
Table 87. Novartis AG Company Details
Table 88. Novartis AG Business Overview
Table 89. Novartis AG Artificial Intelligence in Biomedical Product
Table 90. Novartis AG Revenue in Artificial Intelligence in Biomedical Business (2021-2026) & (US$ Million)
Table 91. Novartis AG Recent Development
Table 92. NVIDIA Corporation Company Details
Table 93. NVIDIA Corporation Business Overview
Table 94. NVIDIA Corporation Artificial Intelligence in Biomedical Product
Table 95. NVIDIA Corporation Revenue in Artificial Intelligence in Biomedical Business (2021-2026) & (US$ Million)
Table 96. NVIDIA Corporation Recent Development
Table 97. Pfizer Company Details
Table 98. Pfizer Business Overview
Table 99. Pfizer Artificial Intelligence in Biomedical Product
Table 100. Pfizer Revenue in Artificial Intelligence in Biomedical Business (2021-2026) & (US$ Million)
Table 101. Pfizer Recent Development
Table 102. Recursion Pharmaceuticals Company Details
Table 103. Recursion Pharmaceuticals Business Overview
Table 104. Recursion Pharmaceuticals Artificial Intelligence in Biomedical Product
Table 105. Recursion Pharmaceuticals Revenue in Artificial Intelligence in Biomedical Business (2021-2026) & (US$ Million)
Table 106. Recursion Pharmaceuticals Recent Development
Table 107. XtalPi Inc Company Details
Table 108. XtalPi Inc Business Overview
Table 109. XtalPi Inc Artificial Intelligence in Biomedical Product
Table 110. XtalPi Inc Revenue in Artificial Intelligence in Biomedical Business (2021-2026) & (US$ Million)
Table 111. XtalPi Inc Recent Development
Table 112. Aidoc Company Details
Table 113. Aidoc Business Overview
Table 114. Aidoc Artificial Intelligence in Biomedical Product
Table 115. Aidoc Revenue in Artificial Intelligence in Biomedical Business (2021-2026) & (US$ Million)
Table 116. Aidoc Recent Development
Table 117. AliveCor Company Details
Table 118. AliveCor Business Overview
Table 119. AliveCor Artificial Intelligence in Biomedical Product
Table 120. AliveCor Revenue in Artificial Intelligence in Biomedical Business (2021-2026) & (US$ Million)
Table 121. AliveCor Recent Development
Table 122. GE Healthcare Company Details
Table 123. GE Healthcare Business Overview
Table 124. GE Healthcare Artificial Intelligence in Biomedical Product
Table 125. GE Healthcare Revenue in Artificial Intelligence in Biomedical Business (2021-2026) & (US$ Million)
Table 126. GE Healthcare Recent Development
Table 127. Imagen Technologies Company Details
Table 128. Imagen Technologies Business Overview
Table 129. Imagen Technologies Artificial Intelligence in Biomedical Product
Table 130. Imagen Technologies Revenue in Artificial Intelligence in Biomedical Business (2021-2026) & (US$ Million)
Table 131. Imagen Technologies Recent Development
Table 132. Vuno Inc. Company Details
Table 133. Vuno Inc. Business Overview
Table 134. Vuno Inc. Artificial Intelligence in Biomedical Product
Table 135. Vuno Inc. Revenue in Artificial Intelligence in Biomedical Business (2021-2026) & (US$ Million)
Table 136. Vuno Inc. Recent Development
Table 137. IDx Technologies Inc. Company Details
Table 138. IDx Technologies Inc. Business Overview
Table 139. IDx Technologies Inc. Artificial Intelligence in Biomedical Product
Table 140. IDx Technologies Inc. Revenue in Artificial Intelligence in Biomedical Business (2021-2026) & (US$ Million)
Table 141. IDx Technologies Inc. Recent Development
Table 142. Siemens Healthcare GmbH Company Details
Table 143. Siemens Healthcare GmbH Business Overview
Table 144. Siemens Healthcare GmbH Artificial Intelligence in Biomedical Product
Table 145. Siemens Healthcare GmbH Revenue in Artificial Intelligence in Biomedical Business (2021-2026) & (US$ Million)
Table 146. Siemens Healthcare GmbH Recent Development
Table 147. Neural Analytics Company Details
Table 148. Neural Analytics Business Overview
Table 149. Neural Analytics Artificial Intelligence in Biomedical Product
Table 150. Neural Analytics Revenue in Artificial Intelligence in Biomedical Business (2021-2026) & (US$ Million)
Table 151. Neural Analytics Recent Development
Table 152. Artificial Intelligence in Biomedical Market Trends
Table 153. Artificial Intelligence in Biomedical Market Drivers
Table 154. Artificial Intelligence in Biomedical Market Challenges
Table 155. Artificial Intelligence in Biomedical Market Restraints
Table 156. Research Programs/Design for This Report
Table 157. Key Data Information from Secondary Sources
Table 158. Key Data Information from Primary Sources
muLu

List of Figures

Figure 1. Artificial Intelligence in Biomedical Product Picture
Figure 2. Global Artificial Intelligence in Biomedical Market Share by Type: 2025 vs 2032
Figure 3. Hardware Features
Figure 4. Software Features
Figure 5. Global Artificial Intelligence in Biomedical Market Share by Application: 2025 vs 2032
Figure 6. Diagnosing Diseases
Figure 7. Developing Drugs
Figure 8. Personalized Treatment
Figure 9. Other
Figure 10. Artificial Intelligence in Biomedical Report Years Considered
Figure 11. Global Artificial Intelligence in Biomedical Market Size (US$ Million), Year-over-Year: 2021-2032
Figure 12. Global Artificial Intelligence in Biomedical Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 13. Global Artificial Intelligence in Biomedical Market Share by Revenue, by Region: 2021 vs 2025
Figure 14. North America Artificial Intelligence in Biomedical Revenue (US$ Million) Growth Rate (2021-2032)
Figure 15. Europe Artificial Intelligence in Biomedical Revenue (US$ Million) Growth Rate (2021-2032)
Figure 16. Asia-Pacific Artificial Intelligence in Biomedical Revenue (US$ Million) Growth Rate (2021-2032)
Figure 17. Latin America Artificial Intelligence in Biomedical Revenue (US$ Million) Growth Rate (2021-2032)
Figure 18. Middle East & Africa Artificial Intelligence in Biomedical Revenue (US$ Million) Growth Rate (2021-2032)
Figure 19. Global Artificial Intelligence in Biomedical Market Share by Players in 2025
Figure 20. Global Top Artificial Intelligence in Biomedical Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Artificial Intelligence in Biomedical as of 2025)
Figure 21. The Top 10 and 5 Players Market Share by Artificial Intelligence in Biomedical Revenue in 2025
Figure 22. North America Artificial Intelligence in Biomedical Market Share by Type (2021-2026)
Figure 23. North America Artificial Intelligence in Biomedical Market Share by Application (2021-2026)
Figure 24. Europe Artificial Intelligence in Biomedical Market Share by Type (2021-2026)
Figure 25. Europe Artificial Intelligence in Biomedical Market Share by Application (2021-2026)
Figure 26. Asia-Pacific Artificial Intelligence in Biomedical Market Share by Type (2021-2026)
Figure 27. Asia-Pacific Artificial Intelligence in Biomedical Market Share by Application (2021-2026)
Figure 28. Latin America Artificial Intelligence in Biomedical Market Share by Type (2021-2026)
Figure 29. Latin America Artificial Intelligence in Biomedical Market Share by Application (2021-2026)
Figure 30. Middle East & Africa Artificial Intelligence in Biomedical Market Share by Type (2021-2026)
Figure 31. Middle East & Africa Artificial Intelligence in Biomedical Market Share by Application (2021-2026)
Figure 32. AstraZeneca Revenue Growth Rate in Artificial Intelligence in Biomedical Business (2021-2026)
Figure 33. Thales Group Revenue Growth Rate in Artificial Intelligence in Biomedical Business (2021-2026)
Figure 34. IBM Corp. Revenue Growth Rate in Artificial Intelligence in Biomedical Business (2021-2026)
Figure 35. ForeSee Medical Revenue Growth Rate in Artificial Intelligence in Biomedical Business (2021-2026)
Figure 36. Atomwise Revenue Growth Rate in Artificial Intelligence in Biomedical Business (2021-2026)
Figure 37. Cloud Pharmaceuticals Revenue Growth Rate in Artificial Intelligence in Biomedical Business (2021-2026)
Figure 38. GNS Healthcare Revenue Growth Rate in Artificial Intelligence in Biomedical Business (2021-2026)
Figure 39. Microsoft Corporation Revenue Growth Rate in Artificial Intelligence in Biomedical Business (2021-2026)
Figure 40. Novartis AG Revenue Growth Rate in Artificial Intelligence in Biomedical Business (2021-2026)
Figure 41. NVIDIA Corporation Revenue Growth Rate in Artificial Intelligence in Biomedical Business (2021-2026)
Figure 42. Pfizer Revenue Growth Rate in Artificial Intelligence in Biomedical Business (2021-2026)
Figure 43. Recursion Pharmaceuticals Revenue Growth Rate in Artificial Intelligence in Biomedical Business (2021-2026)
Figure 44. XtalPi Inc Revenue Growth Rate in Artificial Intelligence in Biomedical Business (2021-2026)
Figure 45. Aidoc Revenue Growth Rate in Artificial Intelligence in Biomedical Business (2021-2026)
Figure 46. AliveCor Revenue Growth Rate in Artificial Intelligence in Biomedical Business (2021-2026)
Figure 47. GE Healthcare Revenue Growth Rate in Artificial Intelligence in Biomedical Business (2021-2026)
Figure 48. Imagen Technologies Revenue Growth Rate in Artificial Intelligence in Biomedical Business (2021-2026)
Figure 49. Vuno Inc. Revenue Growth Rate in Artificial Intelligence in Biomedical Business (2021-2026)
Figure 50. IDx Technologies Inc. Revenue Growth Rate in Artificial Intelligence in Biomedical Business (2021-2026)
Figure 51. Siemens Healthcare GmbH Revenue Growth Rate in Artificial Intelligence in Biomedical Business (2021-2026)
Figure 52. Neural Analytics Revenue Growth Rate in Artificial Intelligence in Biomedical Business (2021-2026)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed
den_biaoTiZhungShi

KEY QUESTIONS ADDRESSED BY THE REPORT

What was the global market size of Artificial Intelligence in Biomedical in 2026?zhanKai
The global market size of Artificial Intelligence in Biomedical in 2026 was 318 Million USD.
What was the global market size of Artificial Intelligence in Biomedical in 2032?shouQi
Which region is expected to have the highest market share?shouQi
Which companies rank high in the global Artificial Intelligence in Biomedical market?shouQi
What is the annual compound growth rate of the global Artificial Intelligence in Biomedical market size from 2026 to 2032?shouQi
den_biaoTiZhungShi

Related Reports

Global Artificial Intelligence in Biomedical Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032

Industry: Service & Software

Published Date: 2026-03-24

Pages: 118 Pages

Report ld: 6270093

CHOOSE LICENSE TYPE
tip

USD 4250.00

tip

USD 6375.00

tip

USD 8500.00

Add to Cart

Add to Cart

Buy Now

Buy Now

HAVE A QUESTION?
SIMON LEE

SIMON LEE

+1-62 6295 2442

English,Chinese

Offline

HITESH

HITESH

+91-86 6998 6909

English, Hindi

Online

TANG XIN

TANG XIN

+81-90 3800 9273

Japanese,English

Online

SUNG-BIN YOON

SUNG-BIN YOON

+82-2883 1278

Korean, English

Online

YUJIE TIAN

YUJIE TIAN

+86-135-2215-3954

Chinese, English

Online

DAMON

DAMON

+86-133 1872 9947

Chinese, English

Online

General Email:
global@qyresearch.com

REPORT COVERAGE

den_ic8

DESCRIPTION

zhankai
den_ic7

OVERVIEW

den_ic7

MARKET SEGMENTATION

den_ic7

WHY THIS REPORT

den_ic7

QYRESEARCH'S STRENGTHS

den_ic8

TABLE OF CONTENTS

den_ic8

TABLE OF FIGURES

den_ic8

RLEATED REPORTS

INTEREST IN THIS REPORT?

yangBenGet A Free Sample

baoJia Request For Quotation

OR

NEED A CUSTOMIZED REPORT?

DingZhiCustomized Report

biaoTi

WORLD WIDE OFFICE

application for samples

Request Sample

Custom reports

Pre-Order Enquiry

Add to Cart

Add to Cart

Buy Now

Buy Now